PMC:7335494 / 57269-58166
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T417 | 95-100 | Body_part | denotes | lipid | http://purl.org/sig/ont/fma/fma67264 |
| T418 | 413-422 | Body_part | denotes | leukocyte | http://purl.org/sig/ont/fma/fma62852 |
| T419 | 858-863 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
| T420 | 864-873 | Body_part | denotes | monocytes | http://purl.org/sig/ont/fma/fma62864 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T70 | 858-863 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T623 | 250-251 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T624 | 366-368 | http://purl.obolibrary.org/obo/CLO_0001818 | denotes | B5 |
| T625 | 401-407 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
| T626 | 411-412 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T627 | 657-658 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T628 | 788-789 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T629 | 858-863 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
| T630 | 858-863 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
| T631 | 864-873 | http://purl.obolibrary.org/obo/CL_0000576 | denotes | monocytes |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T4159 | 33-37 | Chemical | denotes | PGE2 | http://purl.obolibrary.org/obo/CHEBI_15551 |
| T6510 | 39-42 | Chemical | denotes | DHA | http://purl.obolibrary.org/obo/CHEBI_16016|http://purl.obolibrary.org/obo/CHEBI_28125|http://purl.obolibrary.org/obo/CHEBI_28689|http://purl.obolibrary.org/obo/CHEBI_36005 |
| T28793 | 47-50 | Chemical | denotes | EPA | http://purl.obolibrary.org/obo/CHEBI_28364 |
| T51672 | 95-100 | Chemical | denotes | lipid | http://purl.obolibrary.org/obo/CHEBI_18059 |
| T283 | 122-125 | Chemical | denotes | EPA | http://purl.obolibrary.org/obo/CHEBI_28364 |
| T39421 | 156-170 | Chemical | denotes | prostaglandins | http://purl.obolibrary.org/obo/CHEBI_26333 |
| T285 | 190-202 | Chemical | denotes | leukotrienes | http://purl.obolibrary.org/obo/CHEBI_25029 |
| T22263 | 292-302 | Chemical | denotes | eicosanoid | http://purl.obolibrary.org/obo/CHEBI_23899 |
| T287 | 342-345 | Chemical | denotes | EPA | http://purl.obolibrary.org/obo/CHEBI_28364 |
| T1293 | 354-368 | Chemical | denotes | leukotriene B5 | http://purl.obolibrary.org/obo/CHEBI_88493 |
| T7758 | 354-365 | Chemical | denotes | leukotriene | http://purl.obolibrary.org/obo/CHEBI_25029 |
| T290 | 370-374 | Chemical | denotes | LTB5 | http://purl.obolibrary.org/obo/CHEBI_88493 |
| T31572 | 444-447 | Chemical | denotes | ARA | http://purl.obolibrary.org/obo/CHEBI_15843 |
| T84097 | 456-460 | Chemical | denotes | LTB4 | http://purl.obolibrary.org/obo/CHEBI_15647 |
| T293 | 501-504 | Chemical | denotes | EPA | http://purl.obolibrary.org/obo/CHEBI_28364 |
| T49800 | 549-552 | Chemical | denotes | ARA | http://purl.obolibrary.org/obo/CHEBI_15843 |
| T56648 | 588-591 | Chemical | denotes | EPA | http://purl.obolibrary.org/obo/CHEBI_28364 |
| T26739 | 632-635 | Chemical | denotes | ARA | http://purl.obolibrary.org/obo/CHEBI_15843 |
| T297 | 644-648 | Chemical | denotes | PGD2 | http://purl.obolibrary.org/obo/CHEBI_15555 |
| T86697 | 714-718 | Chemical | denotes | PGD2 | http://purl.obolibrary.org/obo/CHEBI_15555 |
| T4872 | 756-759 | Chemical | denotes | EPA | http://purl.obolibrary.org/obo/CHEBI_28364 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T197 | 79-91 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | biosynthesis |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T323 | 0-328 | Sentence | denotes | Besides decreasing production of PGE2, DHA and EPA are also substrates for the biosynthesis of lipid derivatives, but the EPA-derived mediators as series-3 prostaglandins (PGD3) or series-5 leukotrienes are typically less biologically potent, having a lower ability to interact with relevant eicosanoid receptors (Calder, 2015). |
| T324 | 329-476 | Sentence | denotes | For example, EPA-derived leukotriene B5 (LTB5) is almost 100 times less active as a leukocyte chemoattractant than ARA-derived LTB4 (Calder, 2017). |
| T325 | 477-571 | Sentence | denotes | However, in some cases, EPA-derived mediators have similar potency with ARA-derived mediators. |
| T326 | 572-739 | Sentence | denotes | It appears that EPA-derived PGD3 inhibits the effect of the ARA-derived PGD2, due to a stronger interaction with the DP1 receptor compared to PGD2 (Wada et al., 2007). |
| T327 | 740-897 | Sentence | denotes | In other cases, EPA-derived mediators exhibited a similar magnitude of effect (e.g. inhibition of TNF-α production by blood monocytes) (Dooper et al., 2002). |
MyTest
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32640331-25149823-30720920 | 322-326 | 25149823 | denotes | 2015 |
| 32640331-28900017-30720921 | 470-474 | 28900017 | denotes | 2017 |
| 32640331-17519235-30720922 | 733-737 | 17519235 | denotes | 2007 |
| 32640331-12225374-30720923 | 891-895 | 12225374 | denotes | 2002 |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32640331-25149823-30720920 | 322-326 | 25149823 | denotes | 2015 |
| 32640331-28900017-30720921 | 470-474 | 28900017 | denotes | 2017 |
| 32640331-17519235-30720922 | 733-737 | 17519235 | denotes | 2007 |
| 32640331-12225374-30720923 | 891-895 | 12225374 | denotes | 2002 |